Patent details

Basic Information

Publication number:

EP1608685

PCT Application Number:

PCT/US/2004/009246

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP047583729

PCT Publication Number:

WO/2004/087206

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

VEGF ANTAGONISTS FOR THE TREATMENT OF DIABETES

French Title of Invention:

ANTAGONISTES DU FACTEUR DE CROISSANCE ENDOTHELIALE POUR LE TRAITEMENT DU DIABETE

German Title of Invention:

VEGF-ANTAGONISTEN ZUR BEHANDLUNG VON DIABETES

SPC Number:

Dates

Filing date:

26/03/2004

Grant date:

21/02/2007

EP Publication Date:

21/02/2007

PCT Publication Date:

14/10/2004

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

28/12/2005

EP B1 Publication Date:

21/02/2007

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

26/03/2019

Expiration date:

26/03/2024

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

26/03/2004

 

 

Name:

REGENERON PHARMACEUTICALS, INC.

Address:

777 Old Saw Mill River Road, Tarrytown, NY 10591, United States (US)

Agent

Name:

OFFICE FREYLINGER S.A.

From:

21/02/2007

Address:

PO Box 48, 8001, STRASSEN, Luxembourg (LU)

To:

Inventor

1

Name:

SLEEMAN Mark, W.

Address:

United States (US)

2

Name:

WIEGAND Stanley, J.

Address:

United States (US)

Priority

Priority Number:

458790 P

Priority Date:

28/03/2003

Priority Country:

United States (US)

Classification

Main IPC Class:

C07K 19/00;

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

19/02/2018

Last Annual Fee Paid Number:

15

Last Annual Fee Paid Amount:

213 Euro

Payer:

ANAQUA SERVICES (ANC. SGA2)

Filing date	Document type	Number of pages